Your search for "newcastle disease" return 105 results.
Dogs trained for Covid-19 detection in Nouvelle-Aquitaine, France >
"One Health", when public and private actors of human and veterinary health commit together.
Ceva builds on its preventative health strategy with opening of a new European reference for the manufacture of autogenous vaccines >
An innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics.
Ceva commits to helping improve preventative health strategies for Vietnam’s rapidly growing livestock sector >
Hanoi, Vietnam, 16 January 2020 - Ceva Santé Animale signed several agreements with the Vietnam Department of Animal Health (DAH) to accelerate the implementation of preventive health strategies, incl...
ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology >
Berlin, Germany and Libourne, France 01st October 2019 - ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines...
World Veterinary Association and Ceva Santé Animale enlarge the scope of the Global Animal Welfare Awards by adding new award categories >
Ceva Santé Animale (Ceva) and the World Veterinary Association (WVA) enlarge the scope of the Global Animal Welfare Awards to recognize veterinary technicians/nurses and veterinary schools in addition...
Ceva brings together international experts in human cardiology and veterinary to stimulate innovation >
Cardio Symposium Human - Veterinary 2019 (September 17 - Milan)
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries >
Libourne 8th July 2019 - Pig farmers in 12 European countries will now be able to protect their herds against the growing problem of Salmonella Typhimurium. Ceva will launch Salmoporc in Austria, Belg...
Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portf... >
Libourne & Dessau 17th. May 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and...
WVA/Ceva Global Animal Welfare Awards highlight the special role veterinarians play in protecting the health and welfare of animals >
Veterinarians from around the world, who have made significant contributions to the promotion of animal welfare, have been honoured in the 2019 Global Animal Welfare Awards
Ceva Santé Animale announces the launch of ForcerisTM, the first approved injectable combination of gleptoferron and toltrazuril in Europe >
25th April 2019, Libourne – ForcerisTM received the first marketing authorisation from the European Medicines Agency (EMA) for this innovative combination of gleptoferron and toltrazuril to treat neon...